T
Thomas G. Martin
Researcher at University of California, San Francisco
Publications - 117
Citations - 3473
Thomas G. Martin is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Transplantation & Multiple myeloma. The author has an hindex of 25, co-authored 117 publications receiving 2873 citations. Previous affiliations of Thomas G. Martin include Novartis & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Lenalidomide after stem-cell transplantation for multiple myeloma
Philip L. McCarthy,Kouros Owzar,Craig C. Hofmeister,David D. Hurd,Hani Hassoun,Paul G. Richardson,Sergio Giralt,Edward A. Stadtmauer,Daniel J. Weisdorf,Ravi Vij,Jan S. Moreb,Natalie S. Callander,Koen van Besien,Teresa Gentile,Luis Isola,Richard T. Maziarz,Don A. Gabriel,Asad Bashey,Heather Landau,Thomas G. Martin,Muzaffar H. Qazilbash,Denise Levitan,Brian McClune,Robert L. Schlossman,Vera Hars,John Postiglione,Chen Jiang,Elizabeth Bennett,Susan Barry,Linda Bressler,Michael Kelly,Michele Seiler,Cara A. Rosenbaum,Parameswaran Hari,Marcelo C. Pasquini,Mary M. Horowitz,Thomas C. Shea,Steven M. Devine,Kenneth C. Anderson,Charles A. Linker +39 more
TL;DR: Lenalidomide maintenance therapy, initiated at day 100 after hematopoietic stem-cell transplantation, was associated with more toxicity and second cancers but a significantly longer time to disease progression and significantly improved overall survival among patients with myeloma.
Journal ArticleDOI
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.
Raymond S.M. Wong,Raymond S.M. Wong,Sergio Giralt,Sergio Giralt,Thomas G. Martin,Thomas G. Martin,Daniel R. Couriel,Daniel R. Couriel,Athanasios Anagnostopoulos,Athanasios Anagnostopoulos,Chitra Hosing,Borje S. Andersson,Pedro Cano,Pedro Cano,Munir Shahjahan,Munir Shahjahan,Cindy Ippoliti,Cindy Ippoliti,Elihu H. Estey,Elihu H. Estey,John McMannis,John McMannis,James Gajewski,James Gajewski,Richard E. Champlin,Marcos de Lima +25 more
TL;DR: Unrelated donor transplantation is a treatment option for older patients with myeloid malignancies and the results in this cohort of patients are comparable with those reported in younger patients with similarly advanced disease.
Journal ArticleDOI
Thrombopoietin Levels in Patients with Cirrhosis before and after Orthotopic Liver Transplantation
Thomas G. Martin,Kenneth A. Somberg,Y. Gloria Meng,Ralph L. Cohen,Christian A. Heid,Frederic J. de Sauvage,Marc A. Shuman +6 more
TL;DR: The hypothesis was that production of thrombopoietin is altered in patients with cirrhosis and that impaired transcription ofThrombocytopenia mRNA may contribute to this alteration.
Journal ArticleDOI
Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma.
Rachid Baz,Thomas G. Martin,Hui-Yi Lin,Xiuhua Zhao,Kenneth H. Shain,Hearn Jay Cho,Jeffrey L. Wolf,Anuj Mahindra,Ajai Chari,Daniel M. Sullivan,Lisa A Nardelli,Kenneth Lau,Melissa Alsina,Sundar Jagannath +13 more
TL;DR: The combination of PomCyDex results in a superior ORR and PFS compared with PomDex in patients with lenalidomide refractory multiple myeloma.
Journal ArticleDOI
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Philippe Moreau,Shaji Kumar,Jesus San Miguel,Faith E. Davies,Elena Zamagni,Nizar J. Bahlis,Heinz Ludwig,Joseph R. Mikhael,Evangelos Terpos,Fredrik Schjesvold,Thomas G. Martin,Kwee Yong,Brian G.M. Durie,Thierry Facon,Artur Jurczyszyn,Surbhi Sidana,Noopur Raje,Niels W.C.J. van de Donk,Sagar Lonial,Michele Cavo,Sigurdur Y. Kristinsson,Suzanne Lentzsch,Roman Hájek,Kenneth C. Anderson,Cristina João,Hermann Einsele,Pieter Sonneveld,Monika Engelhardt,Rafael Fonseca,Annette Juul Vangsted,Katja Weisel,Rachid Baz,Vania Hungria,Jesus G. Berdeja,Fernando Leal da Costa,Angelo Maiolino,Anders Waage,David H. Vesole,Enrique M. Ocio,Hang Quach,Christoph Driessen,Joan Bladé,Xavier Leleu,Eloisa Riva,Eloisa Riva,Peter Leif Bergsagel,Jian Hou,Wee Joo Chng,Ulf-Henrik Mellqvist,Dominik Dytfeld,Jean-Luc Harousseau,Hartmut Goldschmidt,Jacob P. Laubach,Nikhil C. Munshi,Meral Beksac,Luciano J. Costa,Martin Kaiser,Parameswaran Hari,Mario Boccadoro,Saad Z. Usmani,Sonja Zweegman,Sarah A. Holstein,Orhan Sezer,Simon J. Harrison,Hareth Nahi,Gordon Cook,Maria-Victoria Mateos,S. Vincent Rajkumar,Meletios A. Dimopoulos,Paul G. Richardson +69 more
TL;DR: The International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple myeloma were presented in this article, where the authors integrated the issue of drug access in both low-income and middle-income countries and in high income countries to help guide realworld practice and thus improve patient outcomes.